G. Fonarow

Cardiology and Cardiovascular Medicine · 2001–2018

A researcher in the Science corpus: 36 papers; trusts 5 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 831 citations into it; #164 of 906 by trust here, #16 by citations

Whom G. Fonarow trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Véronique L. Roger
2. M. Redfield
3. Ramachandran S. Vasan
4. C. Yancy
5. Daniel Levy

Who trusts G. Fonarow overall

1. M. Gheorghiade
2. P. Marik
3. C. Yancy
4. M. Flemmer
5. C. Lavie
6. Véronique L. Roger

Papers from G. Fonarow's perspective

Ordered by how strongly the researchers G. Fonarow trusts endorse each paper. Same corpus, a different order for every researcher.

1. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. (Journal of the American Medical Association (JAMA))
2. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. (New England Journal of Medicine)
3. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. (Journal of the American College of Cardiology)
4. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. (Journal of the American Medical Association (JAMA))
5. Obesity and the risk of heart failure. (New England Journal of Medicine)
6. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. (The Lancet)
7. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. (Archives of Internal Medicine)
8. The third universal definition of myocardial infarction
9. Rosuvastatin in older patients with systolic heart failure. (Current Atherosclerosis Reports)
10. Irbesartan in patients with heart failure and preserved ejection fraction. (New England Journal of Medicine)

Their papers

• AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. (2006) — 2,200 citations
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. (2018) — 801 citations
• Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. (2018) — 1,164 citations
• Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches (2017) — 316 citations
• 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) — 823 citations
• Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. (2017) — 968 citations
• 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) — 2,083 citations
• Epidemiology and aetiology of heart failure (2016) — 1,679 citations
• Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. (2016) — 724 citations
• Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition–Heart Failure (BEAT-HF) Randomized Clinical Trial (2016) — 636 citations
• 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) — 669 citations
• The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (2014) — 1,968 citations
• Forecasting the Impact of Heart Failure in the United States (2013) — 2,556 citations
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) — 3,726 citations
• Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. (2013) — 800 citations
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) — 3,814 citations
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) — 9,630 citations
• Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes (2012) — 752 citations
• Effect of nesiritide in patients with acute decompensated heart failure. (2011) — 621 citations
• Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond (2010) — 4,217 citations